Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients

The COVID-19 global pandemic has caused about 4,30 Mln deaths. Recently the first vaccines have been licensed, representing the most powerful weapon available to stop the pandemic. The COVID-19 viral infection in the most severe cases can cause severe lung lesions with the presence of fibrotic tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitiello, Antonio, Ferrara, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
COVID-19 therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444447/
https://www.ncbi.nlm.nih.gov/pubmed/34870154
http://dx.doi.org/10.1016/j.crphar.2021.100056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444447/
https://www.ncbi.nlm.nih.gov/pubmed/34870154
http://dx.doi.org/10.1016/j.crphar.2021.100056

Ejemplares similares